MedTrace Logo

Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)

NCT02152969 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2014-11-19

No results posted yet for this study

Summary

To evaluate Drug-drug interaction

Conditions

Interventions

DRUG

Telmisartan

DRUG

Amlodipine

DRUG

Chlorthalidone

Sponsors & Collaborators

  • Yuhan Corporation

    lead INDUSTRY

Principal Investigators

  • Dong Seok Yim · The Catholic University of Korea

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2014-08-31
Completion
2014-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02152969 on ClinicalTrials.gov